Boston Scientific (BSX) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Boston Scientific · Health Care · ref. ETF XLV · 112 calls · price $43.31
What the company does: Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe.
📈 Boston Scientific (BSX) stock price
$43.31-55.0% over range
Oct 14, 25low $41.58 · high $104.98Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
76% recommend buying · 21 analysts
📊 JPI status : Boston Scientific is no longer in our current JPI rankings, but appeared in the past (2018, 2017) — its upside may be behind it. See the stocks picked in 2018 →
🎯 BSX price target & analyst consensus — price $43.31
The price target · all analysts combined (19 targets)
Highest target · 1 firm of 19$84+94.0%
Median target · of 19 targets$65+50.1%
Lowest target · 3 firms of 19$48+10.8%
Current price$43.31
Where these 19 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
19100%
$48 ↔ $84
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Citigroup — 67% of its targets hit on this sector (516 calls tested). It aims for $48 (+11 %), call made on October 6, 2026, maturing on October 6, 2027 (8 d ago).
The 10 reliable analysts
$56+29 %
The 9 other firms
$70+62 %
How to read it: the 10 reliable firms are not filtered by optimism — 10 aim above the price, 0 below, hence their $56 median. “The 9 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 21 ratings (last 6 months)
Strong Buy00%
Buy1676%
Hold524%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 BSX price target all
All 19 calls, one by one, with our verdict on each firm.
→ See all 19 targets, analyst by analyst💡 The best analysts on BSX most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in BSX? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Boston Scientific? The JPI assistant answers using our backtest data.
📈 Boston Scientific fundamentals: valuation, margins & growth › open the full page
P/E 17.8Net margin 17.5 %Revenue growth +7.5 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 5 %
2023
Rev +12%Profit +145%
2024
Rev +18%Profit +18%
2025
Rev +20%Profit +56%
🏛️ Boston Scientific insider buying: who's buying and how much › open the full page
5 insiders bought8 buys / 6 mo $10.0M👥 Cluster buy
🔎 Detailed analyses
🏛️ Which US Congress members hold Boston Scientific (BSX)?
1 Congress member has disclosed BSX buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Lois Frankel 2× · 45%
✅ Historical analyst reliability on BSX
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Mizuho ↗ | 100% | +39.9% | 4 |
| Stephens & Co. ↗ | 100% | +33.1% | 2 |
| TD Cowen ↗ | 100% | +31.8% | 5 |
| Bernstein ↗ | 100% | +30.5% | 3 |
| B of A Securities ↗ | 100% | +29.1% | 3 |
| SunTrust Robinson Humphrey | 100% | +28.8% | 2 |
| Argus Research ↗ | 100% | +25.4% | 6 |
| Leerink Swann | 100% | +23.5% | 3 |
| Jefferies ↗ | 100% | +19.5% | 3 |
| BMO Capital ↗ | 100% | +16.8% | 3 |
See the other 20 firms
| Leerink Partners ↗ | 0% | -54.3% | 2 |
| Cowen & Co. | 50% | -5.3% | 2 |
| Baird ↗ | 50% | +0.2% | 8 |
| Goldman Sachs ↗ | 67% | +0.2% | 3 |
| Truist Securities ↗ | 69% | +7.3% | 16 |
| Wells Fargo ↗ | 71% | +15.7% | 14 |
| Barclays ↗ | 72% | +17.8% | 18 |
| Raymond James ↗ | 73% | +14.4% | 26 |
| Needham ↗ | 74% | +18.8% | 27 |
| Evercore ISI Group ↗ | 75% | +10.8% | 8 |
| Piper Sandler ↗ | 75% | +13.3% | 4 |
| BTIG ↗ | 75% | +13.7% | 12 |
| UBS ↗ | 75% | +16.4% | 8 |
| Morgan Stanley ↗ | 77% | +15.1% | 22 |
| Canaccord Genuity ↗ | 80% | +17.9% | 15 |
| RBC Capital ↗ | 83% | +25.5% | 18 |
| Credit Suisse | 83% | +40.1% | 6 |
| JP Morgan ↗ | 88% | +23.9% | 8 |
| Stifel ↗ | 88% | +36.7% | 17 |
| Citigroup ↗ | 92% | +30.8% | 24 |
📊 What $1,000 invested in Boston Scientific would be worth › open the full page
In short — $1,000 invested in Boston Scientific 10 years ago would be worth $2,315 today, i.e. +9%/yr on average. Best year: 2024 (+55%), worst: 2020 (-20%). Price performance, excluding dividends.
If I'd invested $1,000 in Boston Scientific
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $478 | -52% |
| 3 years ago | $922 | -8% |
| 5 years ago | $1,187 | +19% |
Return by year (Boston Scientific)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -55% | $448 (-55%) |
| 2025 | +7% | $478 (-52%) |
| 2024 | +55% | $738 (-26%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Boston Scientific
Loading news…
📋 All analyst calls on BSX
Filtered on — · ✕ show all
■ Equal-Weight neutral · not a buy · 🎯$48
Price at call : $41.58 — gap to target +15%
Today : $43.31 — gap to target +11%
🎯 on BSX : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
■ Neutral neutral · not a buy · 🎯$48
Price at call : $42.19 — gap to target +14%
Today : $43.31 — gap to target +11%
🎯 on BSX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Oct 5, 27
matures : Oct 5, 27
Wells Fargo ↗
Sep 24, 26
■ Equal-Weight neutral · not a buy · 🎯$48
Price at call : $44.68 — gap to target +7%
Today : $43.31 — gap to target +11%
🎯 on BSX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Sep 24, 27
matures : Sep 24, 27
Oppenheimer ↗
Sep 21, 26
▲ Outperform · 🎯$65
Price at call : $44.92 — upside +45%
Today : $43.31 — upside +50%
🎯 on BSX : no call matured yet · 📊 on Health : 43.5% · -0.2% (223 calls)
in progress (365j)
matures : Sep 21, 27
matures : Sep 21, 27
■ Neutral neutral · not a buy · 🎯$50
Price at call : $43.55 — gap to target +15%
Today : $43.31 — gap to target +15%
🎯 on BSX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Sep 17, 27
matures : Sep 17, 27
▲ Buy · 🎯$56
Price at call : $44.96 — upside +25%
Today : $43.31 — upside +29%
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Sep 9, 27
matures : Sep 9, 27
▲ Buy · 🎯$56
Price at call : $48.17 — upside +16%
Today : $43.31 — upside +29%
🎯 on BSX : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Aug 25, 27
matures : Aug 25, 27
Argus Research ↗
Jul 31, 26
■ Hold neutral · not a buy
🎯 on BSX : no call matured yet · 📊 on Health : 55.3% · +2.1% (159 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
See the other 104 calls, newest to oldest
▲ Buy · 🎯$67
Price at call : $46.73 — upside +43%
Today : $43.31 — upside +55%
🎯 on BSX : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
▲ Buy · 🎯$61
Price at call : $46.73 — upside +31%
Today : $43.31 — upside +41%
🎯 on BSX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
RBC Capital ↗
Jul 30, 26
▲ Outperform · 🎯$70
Price at call : $46.73 — upside +50%
Today : $43.31 — upside +62%
🎯 on BSX : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
▲ Buy · 🎯$56
Price at call : $46.73 — upside +20%
Today : $43.31 — upside +29%
🎯 on BSX : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Canaccord Genuity ↗
Jul 30, 26
▲ Buy · 🎯$66
Price at call : $46.73 — upside +41%
Today : $43.31 — upside +52%
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Truist Securities ↗
Jul 30, 26
▲ Buy · 🎯$57
Price at call : $46.73 — upside +22%
Today : $43.31 — upside +32%
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Evercore ISI Group ↗
Jul 30, 26
▲ Outperform · 🎯$55
Price at call : $46.73 — upside +18%
Today : $43.31 — upside +27%
🎯 on BSX : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Wells Fargo ↗
Jul 30, 26
■ Equal-Weight neutral · not a buy · 🎯$50
Price at call : $46.73 — gap to target +7%
Today : $43.31 — gap to target +15%
🎯 on BSX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
▲ Buy · 🎯$60
Price at call : $46 — upside +30%
Today : $43.31 — upside +39%
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
Oppenheimer ↗
Jul 27, 26
▲ Outperform · 🎯$85
Price at call : $45.51 — upside +87%
Today : $43.31 — upside +96%
🎯 on BSX : no call matured yet · 📊 on Health : 43.5% · -0.2% (223 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
Truist Securities ↗
Jul 16, 26
▲ Buy · 🎯$62
Price at call : $44.03 — upside +41%
Today : $43.31 — upside +43%
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
▲ Outperform · 🎯$70
Price at call : $44.62 — upside +57%
Today : $43.31 — upside +62%
🎯 on BSX : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
RBC Capital ↗
Jul 13, 26
▲ Outperform · 🎯$85
Price at call : $42.63 — upside +99%
Today : $43.31 — upside +96%
🎯 on BSX : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
▲ Buy · 🎯$57
Price at call : $44.81 — upside +27%
Today : $43.31 — upside +32%
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$65
Price at call : $45.3 — upside +43%
Today : $43.31 — upside +50%
🎯 on BSX : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▲ Buy · 🎯$65
Price at call : $44.23 — upside +47%
Today : $43.31 — upside +50%
🎯 on BSX : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jun 25, 27
matures : Jun 25, 27
▲ Buy · 🎯$67
Price at call : $44.2 — upside +52%
Today : $43.31 — upside +55%
🎯 on BSX : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
▲ Buy · 🎯$65
Price at call : $46.92 — upside +39%
Today : $43.31 — upside +50%
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Jun 16, 27
matures : Jun 16, 27
Truist Securities ↗
Jun 4, 26
▲ Buy · 🎯$64
Price at call : $48.85 — upside +31%
Today : $43.31 — upside +48%
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Buy · 🎯$65
Price at call : $47.69 — upside +36%
Today : $43.31 — upside +50%
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
Canaccord Genuity ↗
Jun 1, 26
▲ Buy · 🎯$70
Price at call : $47.68 — upside +47%
Today : $43.31 — upside +62%
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : Jun 1, 27
matures : Jun 1, 27
Wolfe Research ↗
May 29, 26
■ Peer Perform neutral · not a buy
🎯 on BSX : no call matured yet · 📊 on Health : 60.9% · +4.3% (46 calls)
in progress (365j)
matures : May 29, 27
matures : May 29, 27
▲ Buy · 🎯$70
Price at call : $48.31 — upside +45%
Today : $43.31 — upside +62%
🎯 on BSX : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
Leerink Partners ↗
May 28, 26
▲ Outperform · 🎯$74
Price at call : $48.31 — upside +53%
Today : $43.31 — upside +71%
🎯 on BSX : 0% (2 calls matureds) · 📊 on Health : 53.7% · -6.2% (41 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
▲ Overweight · 🎯$89
Price at call : $48.31 — upside +84%
Today : $43.31 — upside +105%
🎯 on BSX : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
Wells Fargo ↗
May 28, 26
■ Equal-Weight neutral · not a buy · 🎯$55
Price at call : $48.31 — gap to target +14%
Today : $43.31 — gap to target +27%
🎯 on BSX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
▲ Outperform · 🎯$75
Price at call : $56.81 — upside +32%
Today : $43.31 — upside +73%
🎯 on BSX : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : May 19, 27
matures : May 19, 27
B of A Securities ↗
May 18, 26
▲ Buy · 🎯$68
Price at call : $56.81 — upside +20%
Today : $43.31 — upside +57%
🎯 on BSX : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
▲ Buy · 🎯$77
Price at call : $56.81 — upside +36%
Today : $43.31 — upside +78%
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
▲ Buy · 🎯$80
Price at call : $56.81 — upside +41%
Today : $43.31 — upside +85%
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
Canaccord Genuity ↗
Apr 23, 26
▲ Buy · 🎯$71
Price at call : $62.07 — upside +14%
Today : $43.31 — upside +64%
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
RBC Capital ↗
Apr 23, 26
▲ Outperform · 🎯$100
Price at call : $62.07 — upside +61%
Today : $43.31 — upside +131%
🎯 on BSX : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
▲ Overweight · 🎯$96
Price at call : $62.07 — upside +55%
Today : $43.31 — upside +122%
🎯 on BSX : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
Evercore ISI Group ↗
Apr 23, 26
▲ Outperform · 🎯$78
Price at call : $62.07 — upside +26%
Today : $43.31 — upside +80%
🎯 on BSX : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
Wells Fargo ↗
Apr 23, 26
▲ Overweight · 🎯$75
Price at call : $62.07 — upside +21%
Today : $43.31 — upside +73%
🎯 on BSX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
Truist Securities ↗
Apr 23, 26
▲ Buy · 🎯$85
Price at call : $65.69 — upside +29%
Today : $43.31 — upside +96%
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
▲ Outperform · 🎯$78
Price at call : $65.69 — upside +19%
Today : $43.31 — upside +80%
🎯 on BSX : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
Goldman Sachs ↗
Apr 23, 26
▲ Buy · 🎯$84
Price at call : $65.69 — upside +28%
Today : $43.31 — upside +94%
🎯 on BSX : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
▲ Buy · 🎯$77
Price at call : $65.69 — upside +17%
Today : $43.31 — upside +78%
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
▲ Buy · 🎯$100
Price at call : $65.69 — upside +52%
Today : $43.31 — upside +131%
🎯 on BSX : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
▲ Overweight · 🎯$100
Price at call : $64.87 — upside +54%
Today : $43.31 — upside +131%
🎯 on BSX : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
▲ Buy · 🎯$80
Price at call : $64.87 — upside +23%
Today : $43.31 — upside +85%
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
Truist Securities ↗
Oct 1, 25
▲ Buy · 🎯$129
Price at call : $96.22 — upside +34%
Today : $43.31 — upside +198%
Expected +34% · Actual -56% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
-55.7%
stock -56% · XLV +16%
matured Oct 1, 26
Canaccord Genuity ↗
Oct 1, 25
▲ Buy · 🎯$132
Price at call : $95.85 — upside +38%
Today : $43.31 — upside +205%
Expected +38% · Actual -55% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
-54.9%
stock -55% · XLV +16%
matured Oct 1, 26
Leerink Partners ↗
Oct 1, 25
▲ Outperform · 🎯$128
Price at call : $95.85 — upside +34%
Today : $43.31 — upside +196%
Expected +34% · Actual -55% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 0% (2 calls matureds) · 📊 on Health : 53.7% · -6.2% (41 calls)
-54.9%
stock -55% · XLV +16%
matured Oct 1, 26
▲ Buy · 🎯$121
Price at call : $95.85 — upside +26%
Today : $43.31 — upside +179%
Expected +26% · Actual -55% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
-54.9%
stock -55% · XLV +16%
matured Oct 1, 26
▲ Buy · 🎯$132
Price at call : $95.85 — upside +38%
Today : $43.31 — upside +205%
Expected +38% · Actual -55% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
-54.9%
stock -55% · XLV +16%
matured Oct 1, 26
▲ Buy · 🎯$127
Price at call : $97.69 — upside +30%
Today : $43.31 — upside +193%
Expected +30% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
-54.3%
stock -54% · XLV +23%
matured Sep 23, 26
▲ Buy · 🎯$121
Price at call : $97.83 — upside +24%
Today : $43.31 — upside +179%
Expected +24% · Actual -55% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
-55.3%
stock -55% · XLV +23%
matured Sep 19, 26
▲ Buy · 🎯$121
Price at call : $104.34 — upside +16%
Today : $43.31 — upside +179%
Expected +16% · Actual -59% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
-58.8%
stock -59% · XLV +18%
matured Sep 11, 26
Raymond James ↗
Jul 24, 25
▲ Strong Buy · 🎯$124
Price at call : $106.14 — upside +17%
Today : $43.31 — upside +186%
Expected +17% · Actual -57% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-57.1%
stock -57% · XLV +20%
matured Jul 24, 26
Truist Securities ↗
Jul 24, 25
▲ Buy · 🎯$125
Price at call : $106.21 — upside +18%
Today : $43.31 — upside +189%
Expected +18% · Actual -58% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
-58.3%
stock -58% · XLV +20%
matured Jul 24, 26
Leerink Partners ↗
Jun 16, 25
▲ Outperform · 🎯$118
Price at call : $101.49 — upside +16%
Today : $43.31 — upside +172%
Expected +16% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 0% (2 calls matureds) · 📊 on Health : 53.7% · -6.2% (41 calls)
-53.8%
stock -54% · XLV +13%
matured Jun 16, 26
▲ Buy · 🎯$115
Price at call : $104.5 — upside +10%
Today : $43.31 — upside +166%
Expected +10% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
-53.8%
stock -54% · XLV +13%
matured May 28, 26
▲ Buy · 🎯$115
Price at call : $101.9 — upside +13%
Today : $43.31 — upside +166%
Expected +13% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
-41.2%
stock -41% · XLV +4%
matured Apr 24, 26
Raymond James ↗
Apr 24, 25
▲ Strong Buy · 🎯$121
Price at call : $101.9 — upside +19%
Today : $43.31 — upside +179%
Expected +19% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-41.2%
stock -41% · XLV +4%
matured Apr 24, 26
Truist Securities ↗
Apr 24, 25
▲ Buy · 🎯$117
Price at call : $101.9 — upside +15%
Today : $43.31 — upside +170%
Expected +15% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
-41.2%
stock -41% · XLV +4%
matured Apr 24, 26
▲ Buy · 🎯$124
Price at call : $101.14 — upside +23%
Today : $43.31 — upside +186%
Expected +23% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
-38.6%
stock -39% · XLV +5%
matured Apr 23, 26
▲ Buy · 🎯$113
Price at call : $95.25 — upside +19%
Today : $43.31 — upside +161%
Expected +19% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
-33.4%
stock -33% · XLV +8%
matured Apr 16, 26
Truist Securities ↗
Apr 11, 25
▲ Buy · 🎯$113
Price at call : $93.67 — upside +21%
Today : $43.31 — upside +161%
Expected +21% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
-32.6%
stock -33% · XLV +8%
matured Apr 11, 26
Truist Securities ↗
Feb 6, 25
▲ Buy · 🎯$120
Price at call : $105.25 — upside +14%
Today : $43.31 — upside +177%
Expected +14% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
-29.6%
stock -30% · XLV +7%
matured Feb 6, 26
Canaccord Genuity ↗
Feb 6, 25
▲ Buy · 🎯$117
Price at call : $105.25 — upside +11%
Today : $43.31 — upside +170%
Expected +11% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
-29.6%
stock -30% · XLV +7%
matured Feb 6, 26
Raymond James ↗
Feb 6, 25
▲ Strong Buy · 🎯$122
Price at call : $105.25 — upside +16%
Today : $43.31 — upside +182%
Expected +16% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-29.6%
stock -30% · XLV +7%
matured Feb 6, 26
Raymond James ↗
Jan 31, 25
▲ Strong Buy · 🎯$119
Price at call : $103.07 — upside +15%
Today : $43.31 — upside +175%
Expected +15% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-10.9%
stock -11% · XLV +6%
matured Jan 31, 26
Truist Securities ↗
Dec 18, 24
▲ Buy · 🎯$110
Price at call : $88.03 — upside +25%
Today : $43.31 — upside +154%
Expected +25% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
+9.2%
stock +9% · XLV +12%
matured Dec 18, 25
Canaccord Genuity ↗
Dec 9, 24
▲ Buy · 🎯$101
Price at call : $90.2 — upside +12%
Today : $43.31 — upside +133%
Expected +12% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+2.8%
stock +3% · XLV +6%
matured Dec 9, 25
Canaccord Genuity ↗
Oct 24, 24
▲ Buy · 🎯$98
Price at call : $85.1 — upside +15%
Today : $43.31 — upside +126%
Expected +15% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+18.8%
stock +19% · XLV -2%
matured Oct 24, 25
Canaccord Genuity ↗
Oct 21, 24
▲ Buy · 🎯$98
Price at call : $88.05 — upside +11%
Today : $43.31 — upside +126%
Expected +11% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+13.5%
stock +13% · XLV -4%
matured Oct 21, 25
▲ Buy · 🎯$93
Price at call : $86.77 — upside +7%
Today : $43.31 — upside +115%
Expected +7% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+12.6%
stock +13% · XLV -7%
matured Oct 14, 25
Truist Securities ↗
Oct 14, 24
▲ Buy · 🎯$100
Price at call : $86.77 — upside +15%
Today : $43.31 — upside +131%
Expected +15% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
+12.6%
stock +13% · XLV -7%
matured Oct 14, 25
Raymond James ↗
Sep 4, 24
▲ Strong Buy · 🎯$94
Price at call : $81.96 — upside +15%
Today : $43.31 — upside +117%
Expected +15% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+30.9%
stock +31% · XLV -12%
matured Sep 4, 25
Raymond James ↗
Jul 25, 24
▲ Strong Buy · 🎯$91
Price at call : $74.92 — upside +21%
Today : $43.31 — upside +110%
Expected +21% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+41.3%
stock +41% · XLV -10%
matured Jul 25, 25
Canaccord Genuity ↗
Jul 25, 24
▲ Buy · 🎯$88
Price at call : $74.26 — upside +19%
Today : $43.31 — upside +103%
Expected +19% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+42.9%
stock +43% · XLV -8%
matured Jul 25, 25
▲ Buy · 🎯$86
Price at call : $74.26 — upside +16%
Today : $43.31 — upside +99%
Expected +16% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+42.9%
stock +43% · XLV -8%
matured Jul 25, 25
Truist Securities ↗
Jul 16, 24
▲ Buy · 🎯$90
Price at call : $77.41 — upside +16%
Today : $43.31 — upside +108%
Expected +16% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
+35.2%
stock +35% · XLV -12%
matured Jul 16, 25
▲ Buy · 🎯$84
Price at call : $78.14 — upside +7%
Today : $43.31 — upside +94%
Expected +7% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+32.1%
stock +32% · XLV -10%
matured Jul 15, 25
▲ Buy · 🎯$82
Price at call : $77 — upside +6%
Today : $43.31 — upside +89%
Expected +6% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+31.6%
stock +32% · XLV -9%
matured Jun 18, 25
Raymond James ↗
Apr 25, 24
▲ Strong Buy · 🎯$85
Price at call : $73.17 — upside +16%
Today : $43.31 — upside +96%
Expected +16% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+39.6%
stock +40% · XLV -1%
matured Apr 25, 25
▲ Buy · 🎯$82
Price at call : $73.26 — upside +12%
Today : $43.31 — upside +89%
Expected +12% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+39.1%
stock +39% · XLV -1%
matured Apr 24, 25
Raymond James ↗
Feb 1, 24
▲ Strong Buy · 🎯$73
Price at call : $64.82 — upside +13%
Today : $43.31 — upside +69%
Expected +13% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+57.9%
stock +58% · XLV +3%
matured Jan 31, 25
▲ Buy · 🎯$71
Price at call : $64.82 — upside +10%
Today : $43.31 — upside +64%
Expected +10% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+57.9%
stock +58% · XLV +3%
matured Jan 31, 25
Raymond James ↗
Jan 3, 24
▲ Strong Buy · 🎯$67
Price at call : $58.17 — upside +15%
Today : $43.31 — upside +55%
Expected +15% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+55.9%
stock +56% · XLV -0%
matured Jan 2, 25
▲ Buy · 🎯$64
Price at call : $57.81 — upside +11%
Today : $43.31 — upside +48%
Expected +11% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+55.1%
stock +55% · XLV +1%
matured Dec 28, 24
Truist Securities ↗
Dec 22, 23
▲ Buy · 🎯$66
Price at call : $55.99 — upside +18%
Today : $43.31 — upside +52%
Expected +18% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
+60.5%
stock +60% · XLV +3%
matured Dec 21, 24
Canaccord Genuity ↗
Nov 27, 23
▲ Buy · 🎯$64
Price at call : $54.93 — upside +17%
Today : $43.31 — upside +48%
Expected +17% · Actual +65% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+65.2%
stock +65% · XLV +13%
matured Nov 26, 24
▲ Buy · 🎯$60
Price at call : $49.52 — upside +21%
Today : $43.31 — upside +39%
Expected +21% · Actual +71% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+71.2%
stock +71% · XLV +21%
matured Oct 26, 24
Truist Securities ↗
Sep 21, 23
▲ Buy · 🎯$61
Price at call : $53.6 — upside +14%
Today : $43.31 — upside +41%
Expected +14% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
+56.7%
stock +57% · XLV +19%
matured Sep 20, 24
Canaccord Genuity ↗
Sep 21, 23
▲ Buy · 🎯$64
Price at call : $53.6 — upside +19%
Today : $43.31 — upside +48%
Expected +19% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+56.7%
stock +57% · XLV +19%
matured Sep 20, 24
▲ Buy · 🎯$64
Price at call : $53.6 — upside +19%
Today : $43.31 — upside +48%
Expected +19% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+56.7%
stock +57% · XLV +19%
matured Sep 20, 24
▲ Buy · 🎯$65
Price at call : $53.97 — upside +20%
Today : $43.31 — upside +50%
Expected +20% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 50% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+55.5%
stock +55% · XLV +19%
matured Sep 20, 24
Canaccord Genuity ↗
Jul 28, 23
▲ Buy · 🎯$62
Price at call : $51.85 — upside +20%
Today : $43.31 — upside +43%
Expected +20% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+45.8%
stock +46% · XLV +12%
matured Jul 27, 24
Raymond James ↗
Jul 28, 23
▲ Strong Buy · 🎯$61
Price at call : $51.69 — upside +18%
Today : $43.31 — upside +41%
Expected +18% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+46.2%
stock +46% · XLV +11%
matured Jul 27, 24
Truist Securities ↗
Jul 19, 23
▲ Buy · 🎯$61
Price at call : $53.46 — upside +14%
Today : $43.31 — upside +41%
Expected +14% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
+45.1%
stock +45% · XLV +10%
matured Jul 18, 24
Canaccord Genuity ↗
Apr 27, 23
▲ Buy · 🎯$58
Price at call : $52.03 — upside +11%
Today : $43.31 — upside +34%
Expected +11% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+40.6%
stock +41% · XLV +6%
matured Apr 26, 24
▲ Buy · 🎯$54
Price at call : $51.61 — upside +5%
Today : $43.31 — upside +25%
Expected +5% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+31.7%
stock +32% · XLV +4%
matured Apr 16, 24
Truist Securities ↗
Apr 17, 23
▲ Buy · 🎯$59
Price at call : $51.74 — upside +14%
Today : $43.31 — upside +36%
Expected +14% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 58% (12 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
+31.7%
stock +32% · XLV +3%
matured Apr 16, 24
Raymond James ↗
Apr 17, 23
▲ Strong Buy · 🎯$60
Price at call : $51.74 — upside +16%
Today : $43.31 — upside +39%
Expected +16% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+31.7%
stock +32% · XLV +3%
matured Apr 16, 24
Raymond James ↗
Feb 2, 23
▲ Strong Buy · 🎯$56
Price at call : $48.07 — upside +16%
Today : $43.31 — upside +29%
Expected +16% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+33.9%
stock +34% · XLV +7%
matured Feb 2, 24
▲ Buy · 🎯$50
Price at call : $41.16 — upside +21%
Today : $43.31 — upside +15%
Expected +21% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+25.6%
stock +26% · XLV +2%
matured Jul 28, 23
Canaccord Genuity ↗
Jun 29, 22
▲ Buy · 🎯$43
Price at call : $37.27 — upside +15%
Today : $43.31 — upside -1%
Expected +15% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+45.1%
stock +45% · XLV +4%
matured Jun 29, 23
▲ Buy · 🎯$45
Price at call : $38.02 — upside +18%
Today : $43.31 — upside +4%
Expected +18% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+40.7%
stock +41% · XLV +2%
matured Jun 24, 23
Canaccord Genuity ↗
Jun 27, 19
▲ Buy · 🎯$46
Price at call : $42.98 — upside +7%
Today : $43.31 — upside +6%
Expected +7% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
-19.4%
stock -19% · XLV +6%
matured Jun 26, 20
▲ Buy
Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 75% (12 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+43.3%
stock +43% · XLV +15%
matured Nov 30, 18
Frequently asked questions
Should I buy Boston Scientific stock?
This isn't buy advice. For Boston Scientific, the analyst consensus is "Buy", with an average price target of $65.00 (+50% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Boston Scientific). We show the numbers — you decide.
Is it too late to buy Boston Scientific? How high can it go?
The most bullish analyst target on Boston Scientific is $84.00 (+94% above today's price); the average is $65.00. That's the upside they see. Check how reliable those analysts have actually been on Boston Scientific on our site before trusting it.
Is Boston Scientific still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 30 analysts have a real record on Boston Scientific, the best hitting 100% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Will Boston Scientific stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will BSX stock recover (go back up)?
Should you invest in Boston Scientific? The case for and against
The arguments for and against, one by one, from the numbers: why invest in BSX (and why hesitate).
What has Boston Scientific's past performance been?
Historical returns and a "how much if I had invested" calculator: BSX performance & returns.
What is the best month to buy BSX?
The 12 months ranked by the stock's past returns: best & worst month to buy BSX.
Are insiders buying BSX stock?
Executives' and large holders' buys and sells, decoded: insider buying on BSX.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
LLY